Drug Interactions between Valcyte and Valtrex
This report displays the potential drug interactions for the following 2 drugs:
- Valcyte (valganciclovir)
- Valtrex (valacyclovir)
Interactions between your drugs
No interactions were found between Valcyte and Valtrex. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Valcyte
A total of 273 drugs are known to interact with Valcyte.
- Valcyte is in the drug class purine nucleosides.
- Valcyte is used to treat the following conditions:
Valtrex
A total of 92 drugs are known to interact with Valtrex.
- Valtrex is in the drug class purine nucleosides.
- Valtrex is used to treat the following conditions:
Drug and food/lifestyle interactions
valGANciclovir food/lifestyle
Applies to: Valcyte (valganciclovir)
ADJUST DOSING INTERVAL: Food increases the bioavailability of ganciclovir from the prodrug, valganciclovir. In 16 HIV-positive subjects, the administration of valganciclovir 875 mg once daily with a high-fat meal containing approximately 600 calories resulted in a 30% increase in the steady-state area under the plasma concentration-time curve (AUC) and a 14% increase in the peak plasma concentration (Cmax) of ganciclovir, with no delay in the time to reach peak plasma concentration (Tmax). The mechanism is unknown.
MANAGEMENT: The manufacturer recommends that valganciclovir be taken with meals.
References (2)
- (2001) "Product Information. Valcyte (valganciclovir)." Roche Laboratories
- Brown F, Banken L, Saywell K, Arum I (1999) "Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositiv volunteers." Clin Pharmacokinet, 37, p. 167-76
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Acyclovir-like antivirals
Therapeutic duplication
The recommended maximum number of medicines in the 'acyclovir-like antivirals' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'acyclovir-like antivirals' category:
- Valcyte (valganciclovir)
- Valtrex (valacyclovir)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.